History & Overview Annual Report President's Pages Center News Community Affairs Code of Conduct
Make a Gift Cycle for Survival Fred's Team Yankees Universe Fund Thomas Blake Sr. Memorial Research Fund Donating Blood & Platelets Volunteering Thrift Shop Park Avenue Potluck CELEBRATIONS
Press Releases In the News Information for Journalists News@MSKCC
Manhattan New Jersey Long Island Westchester
Working at Memorial Sloan-Kettering Work Sites College Recruitment About Nursing Job Fairs & Career Days IS Careers Job Search & Apply Online
Making an Appointment
Our Publications
Our Publications
Visit PubMed for our journal articles

Because malignant pleural mesothelioma -- the most common form of mesothelioma -- is relatively rare, most physicians see very few patients with this disease and are not familiar with the optimal therapy. As such, patients who suffer from this disease are best served by seeking specialized care at a center with a large volume of mesothelioma patients. At Memorial Sloan-Kettering, we have assembled a team of specialists -- including surgeons, medical oncologists, radiation oncologists, pathologists, and basic scientists -- who are committed to providing the best possible treatments for patients with malignant pleural mesothelioma.

Our Surgical Approach

Determining whether a patient qualifies for surgery and which type of surgery should be used is often a complex process. Some patients with malignant pleural mesothelioma may qualify for a procedure known as a extrapleural pneumonectomy (EPP). In an EPP, a surgeon removes the lining of the lung and the entire lung itself, along with the diaphragm on the affected side of the patient's body and a portion of the lining around the heart. An EPP has serious risks and should only be undertaken by surgeons who perform this operation on a regular basis. At Memorial Sloan-Kettering, our surgeons have been pioneers in establishing the surgical approaches used to treat mesothelioma [PubMed Abstract]. They have led numerous clinical studies and compiled a database of more than 1,000 patients who have been treated for malignant pleural mesothelioma at our center. The information acquired from this body of work helps guide our current treatment choices.

Radiation Therapy

Our radiation oncologists have developed cutting-edge radiation techniques for treating mesothelioma [PubMed Abstract]. In particular, they have amassed a great deal of clinical experience with intensity-modulated radiation therapy (IMRT), which allows for targeted radiation to be administered directly to the pleura [PubMed Abstract]. Currently, clinical trials are ongoing at Memorial Sloan-Kettering to assess the safety and efficacy of this novel approach.

Chemotherapy & Immunotherapy

Our Clinical Trials
Our Clinical Trials
Find out about new research studies for mesothelioma

Our medical oncologists not only care for a large number of patients with pleural mesothelioma but also conduct numerous clinical trials testing new drugs and novel approaches. They have led a national study assessing the role of chemotherapy before extrapleural pneumonectomy and radiation for patients with early-stage disease [PubMed Abstract]. In addition, they are exploring the use of immunotherapies (treatments that stimulate the body's immune system to attach and kill cancer cells) for mesothelioma and recently completed a study with a WT-1 vaccine developed here. (The Wilms tumor protein, encoded by the WT-1 gene, can be used as a target for a patient's immune system.)

Currently, they are leading an international phase III study of a new oral drug called vorinostat for patients who previously received treatment with chemotherapy.

Focus on the Patient

Communication with patients and caregivers is a priority at Memorial Sloan-Kettering. We believe that treating the whole person, not just the disease, is the best approach for patients and family members. At Memorial Sloan-Kettering, we offer a broad range of emotional support programs designed to help patients and family members cope with the range of issues related to life during and after cancer treatment.

Our team of experts, which includes thoracic surgeons, radiation oncologists, and medical oncologists, provides experienced, up-to-date, and thoughtful care for patients diagnosed with pleural mesothelioma.

Last Updated: Dec. 10, 2009
Bookmark and SharePrintEmail This Page